NASDAQ:BCPC - Balchem Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Balchem Co. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $103.18 -8.89 (-7.93 %) (As of 02/21/2020 04:00 PM ET) Add Compare Today's Range$102.18Now: $103.18▼$113.1050-Day Range$102.28MA: $108.24▼$113.6052-Week Range$82.33Now: $103.18▼$113.93Volume173,152 shsAverage Volume74,165 shsMarket Capitalization$3.32 billionP/E Ratio41.94Dividend Yield0.46%Beta1.07 ProfileAnalyst RatingsAdvanced ChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Chemicals & allied products Sub-IndustrySpecialty Chemicals SectorBasic Materials Current SymbolNASDAQ:BCPC Previous Symbol CUSIP05766520 CIK9326 Webhttp://www.balchem.com/ Phone845-326-5600Debt Debt-to-Equity Ratio0.32 Current Ratio3.33 Quick Ratio2.31Price-To-Earnings Trailing P/E Ratio41.94 Forward P/E Ratio32.65 P/E GrowthN/A Sales & Book Value Annual Sales$643.68 million Price / Sales5.16 Cash Flow$4.07 per share Price / Cash Flow25.38 Book Value$21.45 per share Price / Book4.81Profitability EPS (Most Recent Fiscal Year)$3.01 Net Income$78.57 million Net Margins12.43% Return on Equity14.01% Return on Assets9.68%Miscellaneous Employees1,135 Outstanding Shares32,170,000Market Cap$3.32 billion Next Earnings Date5/1/2020 (Estimated) OptionableOptionable Receive BCPC News and Ratings via Email Sign-up to receive the latest news and ratings for BCPC and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:BCPC Rates by TradingView Balchem (NASDAQ:BCPC) Frequently Asked Questions What is Balchem's stock symbol? Balchem trades on the NASDAQ under the ticker symbol "BCPC." How often does Balchem pay dividends? What is the dividend yield for Balchem? Balchem declared an annual dividend on Wednesday, December 18th. Stockholders of record on Monday, December 30th will be paid a dividend of $0.52 per share on Friday, January 17th. This represents a dividend yield of 0.51%. The ex-dividend date is Friday, December 27th. This is an increase from Balchem's previous annual dividend of $0.47. View Balchem's Dividend History. How were Balchem's earnings last quarter? Balchem Co. (NASDAQ:BCPC) released its quarterly earnings data on Friday, February, 21st. The basic materials company reported $0.88 earnings per share for the quarter, beating analysts' consensus estimates of $0.84 by $0.04. The basic materials company had revenue of $166.50 million for the quarter, compared to analyst estimates of $165.55 million. Balchem had a net margin of 12.43% and a return on equity of 14.01%. The firm's revenue for the quarter was up 1.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.77 EPS. View Balchem's Earnings History. When is Balchem's next earnings date? Balchem is scheduled to release their next quarterly earnings announcement on Friday, May 1st 2020. View Earnings Estimates for Balchem. What price target have analysts set for BCPC? 2 equities research analysts have issued twelve-month target prices for Balchem's shares. Their forecasts range from $100.00 to $122.00. On average, they expect Balchem's share price to reach $111.00 in the next year. This suggests a possible upside of 7.6% from the stock's current price. View Analyst Price Targets for Balchem. What is the consensus analysts' recommendation for Balchem? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Balchem. What are Wall Street analysts saying about Balchem stock? Here are some recent quotes from research analysts about Balchem stock: 1. According to Zacks Investment Research, "Balchem Corporation provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. Balchem Company consists of four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. The Industrial Products segment manufactures and supplies certain derivative products into industrial applications. " (2/4/2020) 2. HC Wainwright analysts commented, "Valuation methodology, risks and uncertainties. We utilize a comparable universe-derived EV-to-EBITDA multiple approach. EV-to-EBITDA multiple to our 2019 diluted EBITDA per share of $3.64, we derive a target of $110 per share. Risks include, but are not limited to: (1) slower-than-anticipated growth in Balchem’s base businesses; (2) a global fracking industry slowdown; (3) inability to launch new nutrition segment products; and (4) failure by Balchem’s partner Curemark to obtain approval for its autism drug candidate." (5/6/2019) Has Balchem been receiving favorable news coverage? Media coverage about BCPC stock has been trending very negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Balchem earned a daily sentiment score of -3.5 on InfoTrie's scale. They also assigned headlines about the basic materials company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Balchem. Who are some of Balchem's key competitors? Some companies that are related to Balchem include Ecolab (ECL), Sherwin-Williams (SHW), International Flavors & Fragrances (IFF), Celanese (CE), Albemarle (ALB), RPM International (RPM), Ashland Global (ASH), NewMarket (NEU), W. R. Grace & Co (GRA), Quaker Chemical (KWR), PolyOne (POL), HB Fuller (FUL), Sensient Technologies (SXT), Innospec (IOSP) and Stepan (SCL). What other stocks do shareholders of Balchem own? Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Opko Health (OPK), CVS Health (CVS), Altria Group (MO), Starbucks (SBUX), Walgreens Boots Alliance (WBA), AbbVie (ABBV), AT&T (T), Analog Devices (ADI), Glacier Bancorp (GBCI) and Methanex (MEOH). Who are Balchem's key executives? Balchem's management team includes the folowing people: Mr. Theodore L. Harris, Chairman and Chief Exec. Officer (Age 54)Mr. William A. Backus CPA, Chief Accounting Officer (Age 53)Mr. Mark A. Stach, Gen. Counsel & Corp. Sec.Mr. David F. Ludwig, VP & Gen. Mang. of Industrial Products (Age 61)Mr. Carl Martin Bengtsson, Chief Financial Officer Who are Balchem's major shareholders? Balchem's stock is owned by a number of of institutional and retail investors. Top institutional investors include State Street Corp (2.91%), Conestoga Capital Advisors LLC (2.52%), Fred Alger Management LLC (2.06%), Geode Capital Management LLC (1.36%), New York State Common Retirement Fund (1.33%) and Janus Henderson Group PLC (1.26%). Company insiders that own Balchem stock include Daniel E Knutson, David F Ludwig and Scott C Mason. View Institutional Ownership Trends for Balchem. Which major investors are selling Balchem stock? BCPC stock was sold by a variety of institutional investors in the last quarter, including Thrivent Financial for Lutherans, PNC Financial Services Group Inc., Bank of New York Mellon Corp, Arizona State Retirement System, Bank of America Corp DE, Royce & Associates LP, GW&K Investment Management LLC and First Trust Advisors LP. View Insider Buying and Selling for Balchem. Which major investors are buying Balchem stock? BCPC stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Great West Life Assurance Co. Can, Goldman Sachs Group Inc., Sei Investments Co., Geode Capital Management LLC, Aviva PLC, Barclays PLC and Charles Schwab Investment Management Inc.. Company insiders that have bought Balchem stock in the last two years include Daniel E Knutson and Scott C Mason. View Insider Buying and Selling for Balchem. How do I buy shares of Balchem? Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Balchem's stock price today? One share of BCPC stock can currently be purchased for approximately $103.18. How big of a company is Balchem? Balchem has a market capitalization of $3.32 billion and generates $643.68 million in revenue each year. The basic materials company earns $78.57 million in net income (profit) each year or $3.01 on an earnings per share basis. Balchem employs 1,135 workers across the globe.View Additional Information About Balchem. What is Balchem's official website? The official website for Balchem is http://www.balchem.com/. How can I contact Balchem? Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected] MarketBeat Community Rating for Balchem (NASDAQ BCPC)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 330 (Vote Outperform)Underperform Votes: 291 (Vote Underperform)Total Votes: 621MarketBeat's community ratings are surveys of what our community members think about Balchem and other stocks. Vote "Outperform" if you believe BCPC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BCPC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/22/2020 by MarketBeat.com StaffFeatured Article: Why do earnings reports matter?
